# High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease

> **NCT05578404** · PHASE2 · COMPLETED · sponsor: **Tanta University** · enrollment: 100 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Cholecalciferol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05578404
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-20
- **Primary completion:** 2023-04-20
- **Final completion:** 2023-04-20
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05578404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05578404, "High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05578404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*